5-Demethyltangeretin is more potent than tangeretin in inhibiting dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin tumorigenesis

Journal of Functional Foods

Volumn 11, Issue C, 2014, Pages 528-537

  Ma, Nianhan ^a   Lai, Ching Shu ^b   Chung, Chih Han ^b   Yang, Jinn Moon ^c   Hsu, Kai Cheng ^c   Chen, Chin Yu ^a   Chung, Tao Sheng ^d   Li, Shiming ^e,f   Ho, Chi Tang ^f   Pan, Min Hsiung ^b,g  

^a NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^d Taiwan Landseed Hospital   (Taiwan)

^e HUANGGANG NORMAL UNIVERSITY   (China)

^f RUTGERS UNIVERSITY   (United States)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

5 Demethyltangeretin; DMBA; Inflammation; Tangeretin; TPA

Indexed keywords

CITRUS;

EID: 84926421206     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.08.009     Document Type: Article

References (40)

1. Arafa E., Zhu Q., Barakat B.M., Wani G., Zhao Q., El-Mahdy M.A., Wani A.A. Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. Cancer Research 2009, 69:8910-8917.
2. Charoensinphon N., Qiu P., Dong P., Zheng J., Ngauv P., Cao Y., Li S., Ho C.T., Xiao H. 5-Demethyltangeretin inhibits human nonsmall cell lung cancer cell growth by inducing G2/M cell cycle arrest and apoptosis. Molecular Nutrition & Food Research 2013, 57:2103-2111.
3. Chen K.H., Weng M.S., Lin J.K. Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. Biochemical Pharmacology 2007, 73:215-227.
4. Chiou Y.S., Sang S., Cheng K.H., Ho C.T., Wang Y.J., Pan M.H. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34+ skin stem cells and skin tumors. Carcinogenesis 2013, 34:1315-1322.
5. Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis 2009, 30:1073-1081.
6. Hwang D.M., Kundu J.K., Shin J.W., Lee J.C., Lee H.J., Surh Y.J. cis-9,trans-11-conjugated linoleic acid down-regulates phorbol ester-induced NF-kappaB activation and subsequent COX-2 expression in hairless mouse skin by targeting IkappaB kinase and PI3K-Akt. Carcinogenesis 2007, 28:363-371.
7. Inoue J., Gohda J., Akiyama T., Semba K. NF-kappaB activation in development and progression of cancer. Cancer Science 2007, 98:268-274.
8. Kanaoka S., Takai T., Yoshida K. Cyclooxygenase-2 and tumor biology. Advances in Clinical Chemistry 2007, 43:59-78.
9. Kargi A., Uysal M., Bozcuk H., Coskun H.S., Savas B., Ozdogan M. The importance of COX-2 expression as prognostic factor in early breast cancer. Journal of Balkan Union of Oncology 2013, 18:579-584.
10. Kim M.S., Hur H.J., Kwon D.Y., Hwang J.T. Tangeretin stimulates glucose uptake via regulation of AMPK signaling pathways in C2C12 myotubes and improves glucose tolerance in high-fat diet-induced obese mice. Molecular and Cellular Endocrinology 2012, 358:127-134.
11. Lai C.S., Ho M.H., Tsai M.L., Li S., Badmaev V., Ho C.T., Pan M.H. Suppression of adipogenesis and obesity in high-fat induced mouse model by hydroxylated polymethoxyflavones. Journal of Agricultural and Food Chemistry 2013, 61:10320-10328.
12. Lai C.S., Li S., Chai C.Y., Lo C.Y., Dushenkov S., Ho C.T., Pan M.H., Wang Y.J. Anti-inflammatory and antitumor promotional effects of a novel urinary metabolite, 3',4'-didemethylnobiletin, derived from nobiletin. Carcinogenesis 2008, 29:2415-2424.
13. Lai C.S., Li S., Chai C.Y., Lo C.Y., Ho C.T., Wang Y.J., Pan M.H. Inhibitory effect of citrus 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice. Carcinogenesis 2007, 28:2581-2588.
14. Lai C.S., Tsai M.L., Cheng A.C., Li S., Lo C.Y., Wang Y., Xiao H., Ho C.T., Wang Y.J., Pan M.H. Chemoprevention of colonic tumorigenesis by dietary hydroxylated polymethoxyflavones in azoxymethane-treated mice. Molecular Nutrition & Food Research 2011, 55:278-290.
15. Li S., Lo C.Y., Ho C.T. Hydroxylated polymethoxyflavones and methylated flavonoids in sweet orange (Citrus sinensis) peel. Journal of Agricultural and Food Chemistry 2006, 54:4176-4185.
16. Li S., Wang Y., Wang Z., Xiao H., Lo C.Y., Rawson N., Ho C.T. Quantitative analysis of hydroxylated polymethoxyflavones by high-performance liquid chromatography. Biomedical Chromatography 2010, 24:838-845.
17. Libby P. Inflammatory mechanisms: The molecular basis of inflammation and disease. Nutrition Reviews 2007, 65:S140-S146.
18. Lin P.C., Lin Y.J., Lee C.T., Liu H.S., Lee J.C. Cyclooxygenase-2 expression in the tumor environment is associated with poor prognosis in colorectal cancer patients. Oncology Letters 2013, 6:733-739.
19. Liu L., Xu X., Cheng D., Yao X., Pan S. Structure-activity relationship of citrus polymethoxylated flavones and their inhibitory effects on Aspergillus niger. Journal of Agricultural and Food Chemistry 2012, 60:4336-4341.
20. Lu H., Ouyang W., Huang C. Inflammation, a key event in cancer development. Molecular Cancer Research 2006, 4:221-233.
21. Luo J., Manning B.D., Cantley L.C. Targeting the PI3K-Akt pathway in human cancer: Rationale and promise. Cancer Cell 2003, 4:257-262.
22. Mantovani A. Molecular pathways linking inflammation and cancer. Current Molecular Medicine 2010, 10:369-373.
23. Marks F., Furstenberger G., Muller-Decker K. Tumor promotion as a target of cancer prevention. Recent Results in Cancer Research 2007, 174:37-47.
24. Morley K.L., Ferguson P.J., Koropatnick J. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Letters 2007, 251:168-178.
25. Onda K., Horike N., Suzuki T., Hirano T. Polymethoxyflavonoids tangeretin and nobiletin increase glucose uptake in murine adipocytes. Phytotheraphy Research 2013, 27:312-316.
26. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., Donner D.B. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999, 401:82-85.
27. Pan M.H., Ho C.T. Chemopreventive effects of natural dietary compounds on cancer development. Chemical Society Reviews 2008, 37:2558-2574.
28. Pan M.H., Lai C.S., Dushenkov S., Ho C.T. Modulation of inflammatory genes by natural dietary bioactive compounds. Journal of Agricultural and Food Chemistry 2009, 57:4467-4477.
29. Pan M.H., Lai Y.S., Lai C.S., Wang Y.J., Li S., Lo C.Y., Dushenkov S., Ho C.T. 5-Hydroxy-3,6,7,8,3',4'-hexamethoxyflavone induces apoptosis through reactive oxygen species production, growth arrest and DNA damage-inducible gene 153 expression, and caspase activation in human leukemia cells. Journal of Agricultural and Food Chemistry 2007, 55:5081-5091.
30. Qiu P., Dong P., Guan H., Li S., Ho C.T., Pan M.H., McClements D.J., Xiao H. Inhibitory effects of 5-hydroxy polymethoxyflavones on colon cancer cells. Molecular Nutrition & Food Research 2010, 54(Suppl 2):S244-S252.
31. Qiu P., Guan H., Dong P., Li S., Ho C.T., Pan M.H., McClements D.J., Xiao H. The p53-, Bax- and p21-dependent inhibition of colon cancer cell growth by 5-hydroxy polymethoxyflavones. Molecular Nutrition & Food Research 2011, 55:613-622.
32. Seo J., Lee H.S., Ryoo S., Seo J.H., Min B.S., Lee J.H. Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced proliferation and migration of aortic smooth muscle cells by blocking AKT activation. European Journal of Pharmacology 2011, 673:56-64.
33. Li S., Pan M.-H., Lo C.-Y., Tan D., Wang Y., Shahidi F., Ho C.-T. Chemistry and health effects of polymethoxyflavones and hydroxylated polymethoxyflavones. Journal of Functional Foods 2009, 1:2-12.
34. Sobolewski C., Cerella C., Dicato M., Ghibelli L., Diederich M. The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. International Journal of Cell Biology 2010, 2010:215158.
35. Sun S.Y., Hail N., Lotan R. Apoptosis as a novel target for cancer chemoprevention. Journal of the National Cancer Institute 2004, 96:662-672.
36. Tak P.P., Firestein G.S. NF-kappaB: A key role in inflammatory diseases. Journal of Clinical Investigation 2001, 107:7-11.
37. Thomas-Ahner J.M., Wulff B.C., Tober K.L., Kusewitt D.F., Riggenbach J.A., Oberyszyn T.M. Gender differences in UVB-induced skin carcinogenesis, inflammation, and DNA damage. Cancer Research 2007, 67:3468-3474.
38. Tominari T., Hirata M., Matsumoto C., Inada M., Miyaura C. Polymethoxy flavonoids, nobiletin and tangeretin, prevent lipopolysaccharide-induced inflammatory bone loss in an experimental model for periodontitis. Journal of Pharmacological Sciences 2012, 119:390-394.
39. Van Dross R.T., Hong X., Pelling J.C. Inhibition of TPA-induced cyclooxygenase-2 (COX-2) expression by apigenin through downregulation of Akt signal transduction in human keratinocytes. Molecular Carcinogenesis 2005, 44:83-91.
40. Yoon J.H., Lim T.G., Lee K.M., Jeon A.J., Kim S.Y., Lee K.W. Tangeretin reduces ultraviolet B (UVB)-induced cyclooxygenase-2 expression in mouse epidermal cells by blocking mitogen-activated protein kinase (MAPK) activation and reactive oxygen species (ROS) generation. Journal of Agricultural and Food Chemistry 2011, 59:222-228.